| |
PRODUCT NAME |
ORDER |
 |
1H-INDAZOLE-3,4-DICARBOXYLIC ACID 4-METHYL ESTER |
 |
 |
Pyridine, 1,2,3,6-tetrahydro-1,2,6-trimethyl-, (2R,6S)-rel- (9CI) |
 |
 |
2H-Pyran-2-methanol,6-ethyl-3,6-dihydro-alpha,5-dimethyl-alpha-(1Z)-1-propenyl-,(alphaR,2R,6R)-(9CI) |
 |
 |
Ethanone, 1-[(2R,6R)-6-ethyl-3,6-dihydro-5-methyl-2H-pyran-2-yl]- (9CI) |
 |
 |
L-Proline, 4-(2-propenyl)-, (4R)- (9CI) |
 |
 |
4H-1,2,4-Triazol-4-amine,N-[(4-ethylphenyl)methylene]-(9CI) |
 |
 |
2-Fluorobenzoyl chloride |
 |
 |
Ethanone, 2-chloro-1-(4-hydroxy[1,1-biphenyl]-3-yl)- (9CI) |
 |
 |
2,3,6-tribromo-5-methylpyridine |
 |
 |
2-NITROMETHYL IMIDAZOLE |
 |
 |
2-METHYL-3-ACETYLBENZOIC ACID |
 |
 |
4-(3-PYRIDINYL)-2-THIOPYRIMIDINE |
 |
 |
3,4-Dihydroxy-5-Methoxy Benzaldehyde |
 |
 |
3,4-DIHYDROXY-5-METHOXYBENZOIC ACID METHYL ESTER |
 |
 |
3,4-Dihydroxy-5-methoxy-benzoic acid |
 |
 |
2,3-DIHYDROXY-4-METHOXYBENZOIC ACID |
 |
 |
4-phenylpyrogallol |
 |
 |
2,3,4,6-TETRA-O-ACETYL-ALPHA-D-GLUCOPYRANOSYL FLUORIDE |
 |
 |
1H,1H-PERFLUOROOCTYL METHACRYLATE |
 |
 |
2-Amino-5-fluorobenzotrifluoride |
 |
 |
5-Bromo-2-fluorobenzotrifluoride |
 |
 |
5-Amino-2-bromobenzotrifluoride |
 |
 |
TRIS(CYCLOPENTADIENYL)ERBIUM |
 |
 |
2,4-dichloro-5-(trifluoromethyl)pyrimidine |
 |
 |
4-DIPHENYLPHOSPHINO POLYSTYRENE RESIN, CROSS-LINKED WITH 2% DVB; (1.0-2.0MMOLP/G), 200-400MESH |
 |
 |
2-Pyrimidinethiol,1,2-dihydro-1-methyl-(9CI) |
 |
 |
1,8-Naphthyridine-3-carboxamide,N-[4-(1-methylethoxy)phenyl]-2-(trifluoromethyl)-(9CI) |
 |
 |
2-Propen-1-ol, 3-(2-methyl-5-pyrimidinyl)- (9CI) |
 |
 |
2-Propenal, 3-(2-methyl-5-pyrimidinyl)- (9CI) |
 |
 |
Formamide, N-[3-(dimethylamino)propyl]-N-methyl- (9CI) |
 |
 |
5-AMINO-2-METHOXYBENZOTRIFLUORIDE |
 |
 |
2H-Imidazol-2-one, 1,3-dihydro-1,3-dihydroxy-4,5-dimethyl-, oxime (9CI) |
 |
 |
2(1H)-Pyrimidinone,4-amino-5-fluoro-3,4-dihydro-(9CI) |
 |
 |
1,2,4-Triazolidine-3-thione,4-amino-5-hydrazino-(9CI) |
 |
 |
Acetamide, N-(4,5-dihydro-2,4-dimethyl-5-oxo-4-oxazolyl)- (9CI) |
 |
 |
1,8-Naphthyridin-2(1H)-one,3,3-[(4-methylphenyl)methylene]bis[4-hydroxy-(9CI) |
 |
 |
1,8-Naphthyridin-2(1H)-one,3,3-[(2-nitrophenyl)methylene]bis[4-hydroxy-(9CI) |
 |
 |
6H-[1]Benzopyrano[3,2-c][1,8]naphthyridin-6-one,7-(1,2-dihydro-4-hydroxy-2-oxo-1,8-naphthyridin-3-yl)-4,7-dihydro-(9CI) |
 |
 |
1,8-Naphthyridin-2(1H)-one,3,3-(2,2,2-trichloroethylidene)bis[4-hydroxy-(9CI) |
 |
 |
1,8-Naphthyridin-2(1H)-one,3,3-(2-propenylidene)bis[4-hydroxy-(9CI) |
 |
 |
Cyanamide, [4-amino-3-(3,4-dichlorophenyl)-5,7-dimethyl-1,8-naphthyridin-2-yl]- (9CI) |
 |
 |
4-NITRO-3-(TRIFLUOROMETHYL)ACETANILIDE |
 |
 |
4-Nitro-3-trifluoromethyl aniline |
 |
 |
Pyrrolo[3,4:3,4]pyrazolo[1,5-a]benzimidazole (9CI) |
 |
 |
4-Azaspiro[2.5]octan-7-ol, 5,5-dimethyl- (9CI) |
 |
 |
5-Fluoro-2-nitrobenzotrifluoride |
 |
 |
Cyclohexanecarboxylic acid, 2-[(2-pyridinylamino)carbonyl]- (9CI) |
 |
 |
4-Amino-2-(trifluoromethyl)benzoic acid |
 |
 |
Glu-Glu |
 |
 |
2-Chloro-3,5-dinitrobenzotrifluoride |
 |